Danielle Sheard and Sara Steeves, Costello Medical, Cambridge, UK Strategic Publication Planning A comprehensive understanding of the clinical data and scientific literature in a therapeutic area underpins publication planning. Gap analysis is one long-standing...
Ellen Baum, PhD, and Harry Ma, PhD, Janssen Pharmaceutical Companies of Johnson & Johnson After an “Original” abstract and its corresponding poster have been presented at a scientific or medical congress, publication professionals sometimes face challenges when...
Rafal Swierzewski, PhD Cancer Survivor; Associate Consultant, European Cancer Patient Coalition (ECPC), Brussels, Belgium; Expert, European Medicines Agency (EMA), London, Great Britain; Co-founder and CEO, Foundation for Patients with Rare Diseases “COCARDA,” Lodz,...
For several years, the American Society of Clinical Oncology (ASCO) has offered authors of research funded by academic institutions, not-for-profit organizations, philanthropic foundations, and government agencies an open access publishing option in its journals....
Carolyn Hustad, PhD, Merck & Co., Inc., Kenilworth, NJ In the last five years, an increasing number of pharmaceutical and biotech companies have joined forces to develop and commercialize new compounds or drug combinations rather than go it alone. This trend is...
Molly E. Hoke, PhD, ISMPP CMPP™ Data transparency is a frequently mentioned and is a passionately discussed topic of relevance to, and has implications for, any publications professional working today in the world of clinical trial data generation and dissemination....
